Sinopharm -Molecular PCR Analyzer - Capital Bio DxLab-2A
Non Technical and Terms
- Initial Delivery Time - 30 days
Pricing Incoterm - CIP
- Advance Payments - 40% upfront with a Bank guarantee, 60% on shipping
- Warranty - 12 months
- Manuals - Printed and digital user service manuals
- Shipping - Air, Land or Sea
All Training and Manual materials will be available in English. Some materials will be available in French and Spanish. Where French and Spanish are needed and not available, the supplier will offer translation services in electronic copy. Training shall be available in English or Spanish or French and shall be available to users within two (2) weeks of equipment delivery.
China National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with 200,000 employees and a full chain in the industry covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services.
For further enquiries, please contact
Sinopharm Fortune International Trading Corp.
Address: Fortune Tower, No.4, Hui Xin Dongjie, Chao Yang District, Beijing 100029, China
Tel.: +86-10-8466 3076/ +86-13269815298
These testing devices use sequences of a patient DNA or RNA for markers of potential disease (e.g., SARS-CoV-2). The method most commonly used for this molecular-based process is called RT-PCR (Real Time-Polymerase Chain Reaction)/NAATS (Nucleic Acid Amplification Test). They are capable of performing testing from a point-of-care diagnostic setting up to high complexity. It should be able to perform in diagnostic mode without being continuously monitored. Results should be completed in less than one hour.